Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Johnny Skillicorn-Aston
Building a case for an optimal glaucoma pathway
In January 2021, 604,4012 people were waiting for a first treatment in ophthalmology, 230,872 have waited more than 18 weeks3 and 48,703 have waited more than a year4. How can an optimal glaucoma pathway be achieved and what would the outcomes be for all involved? Back in January 2019, Richard Whittington, then assistant director of commissioning, now chief executive of Local Optical Committee Support Unit, wrote a blog for the NHS England (NHSE) website.
A panel view - how can pharma engage with a changing NHS?
The recent NHS White Paper presents a blueprint for health and social care reform; a proposal for further integration of services built on the foundation of the Long Term Plan. It aims to reduce the burden of bureaucracy and thus ease the yoke of health inequalities; empower local leaders to act and build back better using the learning from the COVID-19 pandemic. These changes were already in train with health systems across the country building integrated care systems (ICS).
How community pharmacy can create capacity in Secondary Care
It is a widely held belief that the pharmaceutical sector needs to understand the challenges faced by its colleagues in Acute Trusts. Secondary Care managers will know very little about community pharmacy and the opportunity it represents. The key is to whet their appetite by creating discourse on the very issues that keep them awake at night.
Partnering with impact across the supply chain, post COVID-19
The COVID-19 pandemic has brought about significant change across all business sectors; unanticipated, unprecedented and a set of new dynamics to which we have all had to adapt. What effect has this had on the wider supply chain and how can partnering with greater impact aid wider recovery of the NHS?
Current trends in compliance
The COVID-19 pandemic has taught us many lessons, but are we missing an age-old one that we all need to learn and act upon? That is, in every crisis there are people waiting to exploit the situation for their gain and your loss. Johnny Skillicorn-Aston from health transformation consultancy, Conclusio, and Andrew Clarke from International Compliance Association (ICA), look at new compliance trends for professionals working in pharma and health supply chains.
Addressing the long-term effects of COVID-19
Johnny Skillicorn-Aston and Jeremy Hooper address the long-term effects of COVID-19 and preventing a negative legacy amongst the population. Addressing the long-term impacts on sickness and disease as a consequence of the COVID-19 pandemic, both causal and additive, will be a continuing challenge for the healthcare sector as it moves through the recovery and restoration agenda. We might understand the epidemiology of the Coronavirus more widely now, but we are less certain on its legacy.
Driving innovation in a modern NHS - Pharmafield
The role of the Accelerated Access Collaborative and how it is driving innovation in a modern NHS is discussed by James Roach and Johnny Skillicorn-Aston of Conclusio. What is pharma’s role and what does it mean for patients? Innovation in the NHS sometimes takes two steps forward and one back. The one back is often a result of reduced traction in mobilisation and delivery which can constrain positive change and reduce the rate of transformation.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Johnny
Contact Johnny, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack